Achieve Life Sciences, Inc. Proceeds from Common Stock Issued
Achieve Life Sciences, Inc. (ACHV) reported Proceeds from Common Stock Issued of $64.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-13.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2020-03-13
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for the quarter ending 2014-12-31 was $0.00.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for the quarter ending 2014-09-30 was $19.51M.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for the quarter ending 2012-12-31 was $0.00.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for the quarter ending 2012-09-30 was $0.00.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for fiscal 2017 was $64.00K.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for fiscal 2014 was $22.37M.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for fiscal 2012 was $53.78M.
- Achieve Life Sciences, Inc. proceeds from issuance of common stock for fiscal 2010 was $32.32M, a 87.84% increase from fiscal 2009.
| Period end | Proceeds from Issuance of Common Stock | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $64.00K 10-K · filed 2020-03-13 | ||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $19.51M derived: sum of 2 quarters · filed 2017-02-23 | $22.37M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $19.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $22.37M 10-Q · filed 2015-11-12 | |||
| 2014-07-02 | $24.00M 10-Q · filed 2014-10-30 | ||||
| 2014-06-30 | $2.86M 10-Q · filed 2015-08-13 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $0.00 derived: sum of 2 quarters · filed 2015-03-26 | $0.00 derived: sum of 3 quarters · filed 2015-03-26 | $53.78M 10-K · filed 2015-03-26 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $53.78M 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $53.78M 10-Q · filed 2012-08-02 | |||
| 2012-03-31 | $53.78M 10-Q · filed 2012-05-03 | ||||
| 2010-12-31 | $32.32M 10-K · filed 2012-03-08 | ||||
| 2009-12-31 | $17.21M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |